Sections of oncology, hematology and thromboembolic diseases
Hematology/Oncology Fellowship Program
The Department of Medical Oncology offers a three year fellowship for internists who have completed an approved residency program. The fellowship combines the resources of Temple University Hospital and Fox Chase Cancer Center. This combined hematology/oncology fellowship is certified by the American Board of Internal Medicine and the Accreditation Council for Graduate Medical Education. Each year up to six new trainees are accepted into the Hematology/Oncology Fellowship Program.
The emphasis of the first two years is on clinical training. One year is spent at Fox Chase Cancer Center. During this year, the fellows are exposed to all aspects of medical oncology care. Fellows longitudinally follow their own patients in continuity clinics over the course of the year. Each fellow has separate clinics where they take care of breast cancer patients, lung cancer patients and GI cancer patients, respectively, under the tutelage of attending physicians who are nationally and internationally recognized for their expertise. There is a fourth half day of clinic consisting of one of the following:
Many of these disease-oriented clinics are multimodality in conjunction with surgical and/or radiation oncology services. There is an emphasis on exposure to the design and conduct of clinical research protocols. There are numerous interdisciplinary conferences and journal clubs in all of the above-named disease sites as well as courses in biostatistics and basic science. There are rotations in supportive oncology where fellows are exposed to pain management and end-of-life issues which are integral components of cancer care. Fellows also rotate through the family risk assessment and genetic counseling programs.
The other clinical year occurs at Temple University Hospital. At this location, fellows will have exposure to all aspects of hematology, both benign and malignant. Temple University is a recognized leader in the field of coagulation research. A general oncology experience is also provided. Fellows also rotate through the bone marrow transplant service. This unit performs both marrow, peripheral blood stem cell, auto- and allogeneic transplants as well as matched unrelated donor and mismatched allogeneic transplants. Exposure to new technology such as non-myeloablative allogeneic transplants is also provided. There are four full time faculty members dedicated to the transplant program.
The third year of the fellowship training is dedicated to research. This research could take the form of basic science bench research or as intensive training in the conduct of clinical research. Senior fellows can become part of a disease-oriented working group and develop a high level of expertise during this year in a particular area. Additional years of research training are available on an individual basis.
There also is a track for those fellows interested in establishing a laboratory-based academic research career. Fellows would do one year of clinical rotations and then concentrate on their laboratory research with only one-half day per week of clinic. These fellows would only be board eligible in one subspecialty, i.e., hematology or oncology.
Advanced training opportunities in clinical research are available through Fox Chase Cancer Center's Clinical Investigator Training Program. The program is open to fellows who have completed at least two years of medical oncology training, surgical oncology training or residents who have completed a radiation therapy residency. Opportunities exist among various scientific programs such as tumor biology, developmental therapeutics, immunotherapy and radiobiology to encourage interdisciplinary interactions. Trainees will work closely with a mentor to design and conduct a clinically-oriented research program. Didactic exposure to clinical research methodology is also an integral component of the program. Eligible individuals include those commencing their research as well as those seeking support for additional years of research training to facilitate their transition into independent investigators. Applicants must be engaged in clinical research which is intimately connected with clinical trials. Materials for submission will include a detailed description of their research project and associated clinical trial, letters of support from prospective mentors and a CV.
In order for applicants to be considered, they must:
Application to the Temple University Hospital/Fox Chase Cancer Center Hematology/Oncology Fellowship Program is coordinated through the Electronic Residency Application Service (ERAS) at https://www.aamc.org/services/eras/. Our fellowship program will also participate in the National Residence Matching Program (NRMP) Fellowship Match in 2006 for fellowships starting July 1, 2007.
The required documents are as follows:
Material should be sent to:
Temple University Hospital
Ambulatory Care Center
Philadelphia, PA 19140
Old Medical School Building
3400 N. Broad Street
Philadelphia, PA 19140
Department of Medical Oncology
Fox Chase Cancer Center 333 Cottman Avenue Philadelphia, PA 19111
Russell J. Schilder, MD